+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Targeted Drug Delivery System Market - Global Forecast 2026-2032- Product Image
Targeted Drug Delivery System Market - Global Forecast 2026-2032- Product Image
New

Targeted Drug Delivery System Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 188 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5336727
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The targeted drug delivery system market is evolving rapidly amid scientific advances, shifting regulatory requirements, and rising patient-centered expectations. Senior executives and stakeholders focused on long-term growth require clear, actionable insight as new delivery modalities and commercialization models take shape.

Market Snapshot

The targeted drug delivery system market is experiencing steady expansion, with a robust compound annual growth rate and a strong revenue outlook through the forecast period. Advances driven by precision medicine and next-generation carrier technologies are accelerating late-stage development and commercialization while intensifying competition. Shifts in payer models, trade policy—including recent US tariffs—and the need for supply chain resilience are reshaping sourcing, manufacturing, and strategic partnerships across leading regions.

Scope & Segmentation

  • Therapeutic Applications: Key focus areas include oncology—where further breakdown considers breast, colorectal, and lung cancer—alongside autoimmune, cardiovascular, central nervous system, and orthopedic applications, each with unique tolerability and endpoint profiles.
  • Delivery Routes: Modalities span inhalation (dry powder inhaler, metered dose inhaler, nebulizer), intraocular, intravenous, local injection, oral, and transdermal, influencing both operational logistics and patient experience factors.
  • Technology Types: Primary categories include antibody drug conjugates, dendrimers, liposomes, microspheres, and nanoparticles, each presenting development, manufacturing, and regulatory nuances.
  • Drug Types: Includes biologics, nucleic acids, peptides, and small molecules. Complexities such as the need for cold chain or specialized delivery vehicles are context-specific for each drug type.
  • End Users: Ambulatory surgical centers, clinics, hospitals, and research institutes, each shaping demand for distinct service delivery models.
  • Sales Channels: Direct tender, hospital pharmacy, online pharmacy, and retail pharmacy channels influence commercialization and payer engagement approaches.
  • Regions: In-depth coverage of the Americas, Europe, Middle East & Africa, and Asia-Pacific, capturing contrasts in innovation pace, regulatory strategy, and patient access models.

Key Takeaways

  • Strategic alignment among clinical, commercial, and technical teams is critical for successful adoption as delivery choices must reflect long-term reimbursement and operational realities.
  • Investments in resilient supply chains, including dual sourcing and inventory strategies, are essential given evolving policy and tariff environments that impact manufacturing and procurement decisions.
  • Regulatory harmonization, proactive authority engagement, and scenario-based planning reduce development risk for complex devices and combined drug-device products.
  • Partnership models—including licensing, joint ventures, and specialized supply agreements—are widely used to bridge capability gaps, accelerate validation, and secure regional market access.
  • Patient-centric design, such as simplifying administration and integrating digital monitoring, enhances adherence, supports real-world outcome measurement, and differentiates offerings in an increasingly data-driven reimbursement landscape.
  • Market dynamics vary regionally, requiring tailored regulatory, supply chain, and commercialization strategies to maximize innovation and patient access opportunities.

Tariff Impact

US tariff changes have shifted supply chain priorities from simple cost optimization to strategic risk management. Procurement leaders now prioritize supplier diversification and closer alignment with contract manufacturers that support integrated regulatory and capacity needs. This environment also places a premium on scenario-based costing, vertical integration, and deeper contingency planning, as import and export complexities influence manufacturing decisions and cross-border partnerships.

Methodology & Data Sources

This report draws from a blend of primary interviews with industry leaders and specialists—including clinical, regulatory, formulation, and supply chain experts—together with secondary evidence from peer-reviewed publications, industry white papers, and regulatory guidelines. Systematic analysis, scenario testing, and internal validation rounds ensure robust, actionable conclusions for strategic planning.

Why This Report Matters

  • Gain segmented, up-to-date insights across the full targeted drug delivery system value chain, enabling informed investment and operational decisions.
  • Anticipate how evolving regional, regulatory, and reimbursement trends will impact program execution and go-to-market strategy.
  • Translate scientific and commercial developments into practical steps for organizational growth and patient access improvement.

Conclusion

The targeted drug delivery system market rewards coordinated strategy, resilient operations, and collaborative partnerships. Senior leaders equipped with nuanced analysis and clear recommendations will be well positioned to shape growth, secure competitive advantage, and enable broader patient access.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Targeted Drug Delivery System Market, by Drug Type
8.1. Biologics
8.2. Nucleic Acids
8.3. Peptides
8.4. Small Molecule
9. Targeted Drug Delivery System Market, by Delivery Route
9.1. Inhalation
9.1.1. Dry Powder Inhaler
9.1.2. Metered Dose Inhaler
9.1.3. Nebulizer
9.2. Intraocular
9.3. Intravenous
9.4. Local Injection
9.5. Oral
9.6. Transdermal
10. Targeted Drug Delivery System Market, by Technology
10.1. Antibody Drug Conjugates
10.2. Dendrimers
10.3. Liposomes
10.4. Microspheres
10.5. Nanoparticles
11. Targeted Drug Delivery System Market, by Therapeutic Application
11.1. Autoimmune
11.2. Cardiovascular
11.3. Central Nervous System
11.4. Oncology
11.4.1. Breast Cancer
11.4.2. Colorectal Cancer
11.4.3. Lung Cancer
11.5. Orthopedic
12. Targeted Drug Delivery System Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Clinics
12.3. Hospitals
12.4. Research Institutes
13. Targeted Drug Delivery System Market, by Sales Channel
13.1. Direct Tender
13.2. Hospital Pharmacy
13.3. Online Pharmacy
13.4. Retail Pharmacy
14. Targeted Drug Delivery System Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Targeted Drug Delivery System Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Targeted Drug Delivery System Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Targeted Drug Delivery System Market
18. China Targeted Drug Delivery System Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. AbbVie Inc.
19.6. AstraZeneca PLC
19.7. F. Hoffmann-La Roche Ltd
19.8. GSK plc
19.9. Johnson & Johnson
19.10. Merck & Co., Inc.
19.11. Novartis AG
19.12. Pfizer Inc.
19.13. Sanofi S.A.
19.14. Teva Pharmaceutical Industries Ltd.
List of Figures
FIGURE 1. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NUCLEIC ACIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NUCLEIC ACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PEPTIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PEPTIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SMALL MOLECULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SMALL MOLECULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRY POWDER INHALER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRY POWDER INHALER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY METERED DOSE INHALER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY METERED DOSE INHALER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NEBULIZER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NEBULIZER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAOCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAOCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAOCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY LOCAL INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY LOCAL INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY LOCAL INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ANTIBODY DRUG CONJUGATES, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ANTIBODY DRUG CONJUGATES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ANTIBODY DRUG CONJUGATES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DENDRIMERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DENDRIMERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DENDRIMERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY LIPOSOMES, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY LIPOSOMES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY LIPOSOMES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY MICROSPHERES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY MICROSPHERES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NANOPARTICLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NANOPARTICLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY AUTOIMMUNE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY AUTOIMMUNE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COLORECTAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DIRECT TENDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DIRECT TENDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. EUROPE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. EUROPE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2032 (USD MILLION)
TABLE 152. EUROPE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 153. EUROPE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 154. EUROPE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 156. EUROPE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. EUROPE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 167. AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 169. AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2032 (USD MILLION)
TABLE 170. AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 171. AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 172. AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 173. AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 174. AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. ASEAN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. ASEAN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 188. ASEAN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2032 (USD MILLION)
TABLE 189. ASEAN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 190. ASEAN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 191. ASEAN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 192. ASEAN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 193. ASEAN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. ASEAN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 195. GCC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. GCC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 197. GCC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2032 (USD MILLION)
TABLE 198. GCC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 199. GCC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 200. GCC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. GCC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 202. GCC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. GCC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 213. BRICS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. BRICS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 215. BRICS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2032 (USD MILLION)
TABLE 216. BRICS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 217. BRICS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 218. BRICS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 219. BRICS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 220. BRICS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. BRICS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 222. G7 TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. G7 TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 224. G7 TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2032 (USD MILLION)
TABLE 225. G7 TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 226. G7 TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 227. G7 TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 228. G7 TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 229. G7 TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 230. G7 TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 231. NATO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. NATO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 233. NATO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2032 (USD MILLION)
TABLE 234. NATO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 235. NATO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 236. NATO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 237. NATO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 238. NATO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 239. NATO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 240. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 245. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 246. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 247. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 248. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 249. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 250. CHINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 251. CHINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 252. CHINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2032 (USD MILLION)
TABLE 253. CHINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 254. CHINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 255. CHINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 256. CHINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 257. CHINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 258. CHINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Targeted Drug Delivery System market report include:
  • AbbVie Inc.
  • AstraZeneca PLC
  • F. Hoffmann-La Roche Ltd
  • GSK plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages188
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 13.92 Billion
Forecasted Market Value ( USD ) by 2032 $ 21.32 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Novel Drug Delivery Systems Market - Global Forecast 2026-2032 - Product Image

Novel Drug Delivery Systems Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Advanced Drug Delivery Systems - A Global Market Overview - Product Image

Advanced Drug Delivery Systems - A Global Market Overview

  • Report
  • 251 Pages
  • Global
From
Drug Delivery Systems Market - Global Forecast 2026-2032 - Product Image

Drug Delivery Systems Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Nano Based Drug Delivery System Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Nano Based Drug Delivery System Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Novel Drug Delivery Systems in Cancer Therapy - Global Strategic Business Report - Product Image

Novel Drug Delivery Systems in Cancer Therapy - Global Strategic Business Report

  • Report
  • 181 Pages
  • Global
From

About the Targeted Drug Delivery System Market

Targeted Drug Delivery System (TDDS) is a specialized area within the broader pharmacological field of Drug Delivery. TDDS aims to direct medication to specific cells, tissues, or organs, thereby increasing the concentration of the drug at the intended site of action while minimizing its presence in the rest of the body. This method potentially reduces side effects and enhances treatment efficacy. The market for these systems encompasses a wide range of technologies and platforms, such as nanoparticles, liposomes, and biodegradable polymers designed to release pharmaceutical compounds in a controlled manner. The field has been propelled by advances in biotechnology, nanotechnology, and molecular biology, which have contributed to the development of novel targeted drug delivery mechanisms. These include antibodies, receptor-mediated delivery systems, and gene-delivery vectors. TDDS is used in addressing various medical conditions, with cancer therapy being a particularly active area due to the need for precise drug delivery to tumor cells. Several companies specialize in the research and development of Targeted Drug Delivery Systems, contributing to the maturation of this market. Some notable players in the field include Alkermes, BIND Therapeutics, DEPArray Technology, Genentech, Immunomedics, Inc., and Kite Pharma. These companies have a diverse product portfolio of targeted delivery technologies and are engaged in the development of innovative treatments for a wide range of diseases, striving to improve therapeutic outcomes and patient quality of life. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.